Over the past 12 months, 2 insiders at Cardiff Oncology, Inc. filed 6 open-market SEC Form 4 transactions on CRDF: 6 purchases worth $1.8M and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on Jul 14, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 14, 26 | Mani MohindruChief Executive Officer, Director | BUY | 34.4K | $1.46 | $50K |
| Jul 14, 26 | Gary W PaceDirector | BUY | 687.3K | $1.46 | $1.0M |
| Jun 18, 26 | Mani MohindruChief Executive Officer | BUY | 24.7K | $1.21 | $30K |
| Jun 18, 26 | Gary W Pace | BUY | 30.0K | $1.22 | $37K |
| Jul 30, 25 | Gary W PaceDirector | BUY | 275.0K | $2.45 | $674K |
| Dec 18, 24 | James E. LevineChief Financial Officer | BUY | 2.4K | $5.00 | $12K |
| Dec 17, 24 | James E. LevineChief Financial Officer | BUY | 2.8K | $5.42 | $15K |
| Dec 16, 24 | James E. LevineChief Financial Officer | BUY | 2.6K | $3.83 | $10K |
| Dec 12, 24 | Renee P TannenbaumDirector | BUY | 10.0K | $3.42 | $34K |
| Dec 11, 24 | Gary W PaceDirector | BUY | 350.1K | $2.60 | $910K |
| Dec 19, 23 | Gary W PaceDirector | BUY | 30.0K | $1.37 | $41K |
| Nov 10, 23 | Gary W PaceDirector | BUY | 22.9K | $0.98 | $22K |
| Nov 25, 22 | Mark ErlanderChief Executive Officer | BUY | 10.0K | $1.43 | $14K |
| Sep 19, 22 | Lale WhiteDirector | BUY | 15.0K | $1.64 | $25K |
| Sep 16, 22 | James O ArmitageDirector | BUY | 13.0K | $1.56 | $20K |
| Sep 16, 22 | James E. LevineChief Financial Officer | BUY | 30.0K | $1.56 | $47K |
| Sep 15, 22 | Gary W PaceDirector | BUY | 150.0K | $1.71 | $257K |
| Sep 15, 22 | Renee P TannenbaumDirector | BUY | 6.4K | $1.72 | $11K |
| Sep 21, 21 | Gary W PaceDirector | BUY | 30.0K | $6.75 | $203K |
| Sep 10, 21 | James E. LevineChief Financial Officer | BUY | 10.0K | $6.62 | $64K |
Over the past 12 months, insiders at Cardiff Oncology, Inc. filed 6 open-market purchases worth $1.8M and 0 sales worth $0 on CRDF, which makes them net buyers over the period. The most recent Form 4 was filed on Jul 14, 26.
The largest recent open-market CRDF insider purchase in our data was $1.0M by Gary W Pace, Director, filed on Jul 14, 26.
2 different insiders at Cardiff Oncology, Inc. filed open-market SEC Form 4 transactions on CRDF over the last 12 months.
InsiderTape plots every CRDF insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Cardiff Oncology, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →